Par6 is an essential mediator of apoptotic response to transforming growth factor beta in NMuMG immortalized mammary cells.

Abstract:

BACKGROUND:We previously observed that the TGFbeta-Par6 pathway mediates loss of polarity and apoptosis in NMuMG cells. Here we investigate the contribution of Par6 versus TGFbeta receptor I activation to TGFbeta-induced apoptosis in association with changes in apico-basal polarity. We focus on the effect of Par6 activation on alpha6beta4 integrin expression and localization, and Nuclear Factor-kappaB (p65/RelA) activation, previously shown to mediate polarity-dependent cell survival. METHODS:Using immunoblotting and/or immunofluorescence we investigated the effect of TGFbeta1 on apoptosis, alpha6, beta4 and beta1 integrin expression/localization, and p65/RelA phosphorylation/localization in monolayer and three-dimensional (3D) cultures of NMuMG cells with an overactive or inactive Par6 pathway. Results were quantified by band densitometry or as percent of 3D structures displaying a phenotype. Differences among means were compared by two-way ANOVA. RESULTS:Blocking Par6 activation inhibits TGFbeta-induced apoptosis. Par6 overactivation enhances TGFbeta-induced apoptosis, notably after 6-day exposure to TGFbeta (p < 0.001), a time when parental NMuMG cells no longer respond to TGFbeta apoptotic stimuli. 48-hour TGFbeta treatment reduced beta4 integrin levels in NMuMG monolayers and significantly reduced the basal localization of alpha6 (p < 0.001) and beta4 (p < 0.001) integrin in NMuMG 3D structures, which was dependent on both Par6 and TGFbeta receptor I activation and paralleled apoptotic response. After 6-day exposure to TGFbeta, Par6-dependent changes to beta4 integrin were no longer apparent, but there was reduced phosphorylation of p65/RelA (p < 0.001) only in Par6 overexpressing cells. Differences in p65/RelA localization were not observed among the different cell lines after 48-hour TGFbeta exposure. CONCLUSIONS:Par6 and TGFbeta receptor I activation are both necessary for TGFbeta-induced apoptosis in NMuMG cells. Importantly, Par6 overexpression enhances the sensitivity of NMuMG to TGFbeta-induced apoptosis, notably upon prolonged exposure to this growth factor, when NMuMG parental cells are usually apoptosis-resistant. Thus, endogenous Par6 level might be important in determining whether TGFbeta will function as either a pro-apoptotic or pro-survival factor in breast cancer, and potentially aid in predicting patient's prognosis and therapy response.

journal_name

Cancer Cell Int

authors

Avery-Cooper G,Doerr M,Gilbert RW,Youssef M,Richard A,Huether P,Viloria-Petit AM

doi

10.1186/1475-2867-14-19

subject

Has Abstract

pub_date

2014-03-01 00:00:00

pages

19

issue

1

issn

1475-2867

pii

1475-2867-14-19

journal_volume

14

pub_type

杂志文章
  • The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.

    abstract:Background:New drugs for adrenocortical carcinoma (ACC) are needed because most patients undergo rapid disease progression despite surgery and adjuvant therapy with mitotane. In this study, we aimed to investigate the in vitro effects of different chemotherapy drugs, alone or combined with mitotane, on the viability of...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-018-0527-x

    authors: Silveira E,Cavalcante IP,Kremer JL,de Mendonça POR,Lotfi CFP

    更新日期:2018-03-01 00:00:00

  • Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment.

    abstract:Background:Drug resistance to 5-fluorouracil (5-FU) and recurrence after chemotherapy in colorectal cancer remain a challenge to be resolved for the improvement of patient outcomes. It is recognized that a variety of secretory proteins released from the tumor cells exposed to chemo-drugs into the tumor microenvironment...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-01541-z

    authors: Chang S,Huang J,Niu H,Wang J,Si Y,Bai Z,Cheng S,Ding W

    更新日期:2020-09-14 00:00:00

  • Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer.

    abstract:Background:Kinesin superfamily (KIFs) has a long-reported significant influence on the initiation, development, and progress of breast cancer. However, the prognostic value of whole family members was poorly done. Our study intends to demonstrate the value of kinesin superfamily members as prognostic biomarkers as well...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-01191-1

    authors: Li TF,Zeng HJ,Shan Z,Ye RY,Cheang TY,Zhang YJ,Lu SH,Zhang Q,Shao N,Lin Y

    更新日期:2020-04-15 00:00:00

  • New insights into the association between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk.

    abstract:Background:Many epidemiological studies have investigated association of AXIN2 variants on overall cancer risks; however, the available results remain inconsistent. Methods:An updated analysis was conducted to ascertain a more accurate estimation of the correlation between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G po...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-019-0840-z

    authors: Xu B,Yuan W,Shi L,Zuo L,Wu XY,Zhang W,Wen Q

    更新日期:2019-05-06 00:00:00

  • Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter.

    abstract:OBJECTIVE:The objective of this study was to evaluate the anti-tumor effects of Ad/gTRAIL (an adenoviral vector in which expression of GFP and TRAIL is driven by a human telomerase reverse transcriptase promoter, hTERT) on malignant meningiomas and gliomas. BACKGROUND:Gliomas and meningiomas are the two most common ty...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-11-35

    authors: Li JT,Bian K,Zhang AL,Kim DH,Ashley WW,Nath R,McCutcheon I,Fang B,Murad F

    更新日期:2011-10-28 00:00:00

  • Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.

    abstract:Background:Long noncoding RNAs (lncRNAs) play essential roles in tumor progression. However, the functions and targets of lncRNAs in neuroblastoma (NB) progression still remain to be determined. In this study, we aimed to investigate the effect of lncRNA DLX6 antisense RNA 1 (DLX6-AS1) on NB and the underlying mechanis...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-019-0968-x

    authors: Zhang HY,Xing MQ,Guo J,Zhao JC,Chen X,Jiang Z,Zhang H,Dong Q

    更新日期:2019-11-27 00:00:00

  • Pathobiology of cancer metastasis: a short account.

    abstract:: Cancer-initiating cells display aberrant functional and phenotypic characteristics of normal stem cells from which they evolved by accumulation of multiple cytogenetic and/or epigenetic alterations. Signal transduction pathways which are essential for normal stem cell function are abnormally expressed by cancer cells...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-12-24

    authors: Feller L,Kramer B,Lemmer J

    更新日期:2012-06-07 00:00:00

  • The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.

    abstract::Colorectal cancer (CRC) is a complex and molecularly heterogeneous disease representing one of the most frequent causes of cancer-related death worldwide. About 8-15% of CRCs harbor a mutation in BRAF gene, a proto-oncogene involved in cell proliferation, differentiation and survival through the MAPK signaling cascade...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审

    doi:10.1186/s12935-020-1117-2

    authors: Fanelli GN,Dal Pozzo CA,Depetris I,Schirripa M,Brignola S,Biason P,Balistreri M,Dal Santo L,Lonardi S,Munari G,Loupakis F,Fassan M

    更新日期:2020-01-29 00:00:00

  • Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.

    abstract:BACKGROUND:Chemoresistance is a major obstacle to successful chemotherapy for colorectal cancer. Eukaryotic translation initiation factor 5A2 (eIF5A2), one of the two isoforms in the eIF5A family, has been reported to be a new oncogene in many types of human cancer. In the present study, we aimed to investigate whether...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-015-0250-9

    authors: Bao Y,Lu Y,Wang X,Feng W,Sun X,Guo H,Tang C,Zhang X,Shi Q,Yu H

    更新日期:2015-11-17 00:00:00

  • Ibrutinib in B-cell lymphoma: single fighter might be enough?

    abstract:Background:In recent years, the B cell receptor (BCR) signaling pathway has become a "hot point" because it plays a critical role in B-cell proliferation and function. Bruton's tyrosine kinase (BTK) is overexpressed in many subtypes of B-cell lymphoma as a downstream kinase in the BCR signaling pathway. Ibrutinib, the ...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审

    doi:10.1186/s12935-020-01518-y

    authors: Xue C,Wang X,Zhang L,Qu Q,Zhang Q,Jiang Y

    更新日期:2020-09-29 00:00:00

  • ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.

    abstract:Background:Angioimmunoblastic T cell lymphoma (AITL) is a distinct subtype of peripheral T cell lymphoma and associated with poor outcomes. The activation status of T cell receptor (TCR) signaling has recently become a focus of attention in terms of the therapeutic targets. However, the molecular pathogenesis mechanism...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-019-0754-9

    authors: Liu Y,Wang X,Deng L,Ping L,Shi Y,Zheng W,Lin N,Wang X,Tu M,Xie Y,Liu W,Ying Z,Zhang C,Pan Z,Wang X,Ding N,Song Y,Zhu J

    更新日期:2019-02-14 00:00:00

  • Identified IGSF9 association with prognosis and hypoxia in nasopharyngeal carcinoma by bioinformatics analysis.

    abstract:Background:Despite improvements in nasopharyngeal carcinoma (NPC) treatment, patients with recurrence and metastasis still have a poor prognosis. Thus, the identification of novel biomarkers is urgently needed to predict outcomes and tailor treatment for NPC. Methods:Four data sets were downloaded from Gene Expression...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-01587-z

    authors: Huang D,Liu Q,Zhang W,Huang C,Zheng R,Xie G,Wang H,Jia B,Shi J,Yuan Y,Deng M

    更新日期:2020-10-12 00:00:00

  • MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7.

    abstract:BACKGROUND:MicroRNAs are a class of small non-coding RNAs that are involved in many important physiological and pathological processes by regulating gene expression negatively. The purpose of this study was to investigate the effect of miR-32 on cell proliferation, migration and apoptosis and to determine the functiona...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-017-0383-0

    authors: Xia W,Zhou J,Luo H,Liu Y,Peng C,Zheng W,Ma W

    更新日期:2017-01-25 00:00:00

  • Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases.

    abstract:BACKGROUND:Blockade of the angiotensin (ANG) II type 1 receptor (AT1R) inhibits tumour growth in several cancers, including colorectal cancer (CRC) liver metastases. While AT1R blockade has been extensively studied, the potential of targeting the antagonistically acting AT2R in cancer has not been investigated. This st...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-10-19

    authors: Ager EI,Chong WW,Wen SW,Christophi C

    更新日期:2010-06-28 00:00:00

  • Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis.

    abstract:BACKGROUND:Bladder cancer (BCa) is a malignant tumor that occurs on the mucosa of the bladder, in which dysregulated long non-coding RNAs (lncRNAs) are involved. This study investigated the effect of lncRNA small nucleolar RNA host gene 1 (SNHG14) on the biological characteristics of BCa cells from microRNA (miR)-211-3...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-01717-7

    authors: Feng R,Li Z,Wang X,Ge G,Jia Y,Wu D,Ji Y,Wang C

    更新日期:2021-01-22 00:00:00

  • Sorting and identification of side population cells in the human cervical cancer cell line HeLa.

    abstract:BACKGROUND:Several reports have revealed that cancer stem cells (CSCs) exist in many types of solid tumors. Some studies have demonstrated that side population (SP) cells isolated from diverse cancer lines harbor cancer stem-like properties, but there are few reports examining the characteristic of SP cells in human ce...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-14-3

    authors: Qi W,Zhao C,Zhao L,Liu N,Li X,Yu W,Wei L

    更新日期:2014-01-13 00:00:00

  • Analysis of PD-1 related immune transcriptional profile in different cancer types.

    abstract:Background:Programmed cell death 1 (PD-1) functions as an immune checkpoint in the process of anti-tumor immune response. The PD-1 blockade is now becoming a fundamental part in cancer immunotherapy. So it's essential to elicit the PD-1 related immune process in different types of cancer. Methods:The Cancer Genome Atl...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-018-0712-y

    authors: Shang J,Song Q,Yang Z,Sun X,Xue M,Chen W,Yang J,Wang S

    更新日期:2018-12-27 00:00:00

  • Melatonin and non-small cell lung cancer: new insights into signaling pathways.

    abstract::Non-small-cell lung cancer (NSCLC) is a type of malignancy with progressive metastasis having poor prognosis and lowered survival resulting from late diagnosis. The therapeutic approaches for the treatment of this incurable cancer are chemo- and radiotherapy. Since current treatments are insufficient and because of dr...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审

    doi:10.1186/s12935-019-0853-7

    authors: Pourhanifeh MH,Sharifi M,Reiter RJ,Davoodabadi A,Asemi Z

    更新日期:2019-05-16 00:00:00

  • Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase.

    abstract:Background:Casticin, an isoflavone compound extracted from the herb Fructus Viticis, has demonstrated anti-inflammatory and anticancer activities and properties. The aim of this study was to investigate the effects and mechanisms of casticin in nasopharyngeal carcinoma (NPC) cells and to determine its potential for tar...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-019-1069-6

    authors: Liu J,Yang J,Hou Y,Zhu Z,He J,Zhao H,Ye X,Li D,Wu Z,Huang Z,Hao B,Yao K

    更新日期:2019-12-21 00:00:00

  • SMAD6, positively regulated by the DNM3OS-miR-134-5p axis, confers promoting effects to cell proliferation, migration and EMT process in retinoblastoma.

    abstract:Background:Retinoblastoma (RB) is acknowledged to be the commonest intraocular malignancy in infants and children and the outcome of RB patients is unfavorable due to limited early diagnosis and effective therapy. SMAD family member 6 (SMAD6) has been reported in the initiation and progression of human cancers by actin...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-1103-8

    authors: Wang H,Ji X

    更新日期:2020-01-22 00:00:00

  • Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.

    abstract:BACKGROUND:Breast cancer (BrCa) is the most common female malignancy worldwide and has the highest morbidity among all cancers in females. Unfortunately, the mechanisms of BrCa growth and metastasis, which lead to a poor prognosis in BrCa patients, have not been well characterized. METHODS:Immunohistochemistry (IHC) w...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-01733-7

    authors: Hang C,Zhao S,Wang T,Zhang Y

    更新日期:2021-01-06 00:00:00

  • Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells.

    abstract:BACKGROUND:Alterations in the processing of the genetic information in carcinogenesis result from stable genetic mutations or epigenetic modifications. It is becoming clear that nucleosomal histones are central to proper gene expression and that aberrant DNA methylation of genes and histone methylation plays important ...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-8-15

    authors: Watanabe H,Soejima K,Yasuda H,Kawada I,Nakachi I,Yoda S,Naoki K,Ishizaka A

    更新日期:2008-11-03 00:00:00

  • Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.

    abstract::BACKGROUND: Mast cells are known to accumulate at sites of inflammation and upon activation to release their granule content, e.g. histamine, cytokines and proteases. The secretory leukocyte protease inhibitor (SLPI) is produced in the respiratory mucous and plays a role in regulating the activity of the proteases. RE...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-3-14

    authors: Hollander C,Nyström M,Janciauskiene S,Westin U

    更新日期:2003-08-20 00:00:00

  • Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.

    abstract:BACKGROUND:Natural killer (NK) cells eliminate virus-infected and tumor cells through the release of perforins and granzymes; they also produce Interferon gamma (IFN-γ) and Tumor necrosis factor alpha (TNF-α), which induce apoptosis in target cells. Many tumors express Heme oxygenase 1 (HO-1), and this expression has b...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-014-0100-1

    authors: Gómez-Lomelí P,Bravo-Cuellar A,Hernández-Flores G,Jave-Suárez LF,Aguilar-Lemarroy A,Lerma-Díaz JM,Domínguez-Rodríguez JR,Sánchez-Reyes K,Ortiz-Lazareno PC

    更新日期:2014-10-01 00:00:00

  • p62 acts as an oncogene and is targeted by miR-124-3p in glioma.

    abstract:Background:Glioma is the most common central nervous system (CNS) tumour. p62, an important autophagy adaptor, plays a crucial role in cancer. However, the role of p62 in the progression of glioma is poorly characterized. Methods:We examined the expression of p62 in glioma tissues and cell lines. Then we investigated ...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-019-1004-x

    authors: Deng D,Luo K,Liu H,Nie X,Xue L,Wang R,Xu Y,Cui J,Shao N,Zhi F

    更新日期:2019-11-06 00:00:00

  • miR-190-5p in human diseases.

    abstract::miRNAs, a major class of small noncoding RNAs approximately 18-25 nucleotides in length, function by repressing the expression of target genes through binding to complementary sequences in the 3'-UTRs of target genes. Emerging evidence has highlighted their important roles in numerous diseases, including human cancers...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审

    doi:10.1186/s12935-019-0984-x

    authors: Yu Y,Cao XC

    更新日期:2019-10-07 00:00:00

  • Reshaping the role of m6A modification in cancer transcriptome: a review.

    abstract::N6-methyl-adenosine(m6A) modification emerges as an abundant and dynamic regulation throughout the Eukaryotic transcriptome. Dysregulation of the m6A regulators has increasingly been found in many neoplasms. It is reasonable to believe that m6A changes the fate of cancer cells and subsequently affected all aspects of ...

    journal_title:Cancer cell international

    pub_type: 杂志文章,评审

    doi:10.1186/s12935-020-01445-y

    authors: Yang G,Sun Z,Zhang N

    更新日期:2020-07-29 00:00:00

  • Mammaglobin as a potential molecular target for breast cancer drug delivery.

    abstract:BACKGROUND:Mammaglobin (MAM) has been used as a specific molecular marker for breast cancer diagnosis. Recently, several groups of researchers proposed a number of therapeutic strategies targeting this molecule. Some of the strategies are based upon an essential but not demonstrated hypothesis - mammaglobin is associat...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-9-8

    authors: Zuo L,Li L,Wang Q,Fleming TP,You S

    更新日期:2009-03-23 00:00:00

  • Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis.

    abstract:Background:Abnormally expressed circular RNAs (circRNAs) are implicated in the development and treatment of gastric cancer (GC). Previous study has reported that hsa_circ_0003159 is expressed in GC. However, the role and mechanism of hsa_circ_0003159 in GC progression remain unclear. Methods:GC tissues and normal tiss...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/s12935-020-1119-0

    authors: Wang J,Lv W,Lin Z,Wang X,Bu J,Su Y

    更新日期:2020-02-19 00:00:00

  • Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells.

    abstract:BACKGROUND:Castration-resistance in prostate cancer (PC) is a critical event hallmarking a switch to a more aggressive phenotype. Neuroendocrine differentiation and upregulation of NFκB transcriptional activity are two mechanisms that have been independently linked to this process. METHODS:We investigated these two pa...

    journal_title:Cancer cell international

    pub_type: 杂志文章

    doi:10.1186/1475-2867-11-13

    authors: Patrikidou A,Vlachostergios PJ,Voutsadakis IA,Hatzidaki E,Valeri RM,Destouni C,Apostolou E,Daliani D,Papandreou CN

    更新日期:2011-05-15 00:00:00